Floatz logo

Msj-0011

Anovulation

Merck KGaA, Darmstadt, GermanyPhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Anovulation cohort.

Asset / SponsorPhaseRating
CLOMIPHENE CITRATE
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Phase 4BBB
Letrozole
GABRIEL MONTEIRO PINHEIRO
Phase 4BBB
Metformin
Ain Shams Maternity Hospital
Phase 4BBB
Folate
University Magna Graecia
Phase 4BB
Hcg
Assiut University
Phase 3BB

View all 15 →

Same molecule, other indications

Msj-0011 is also rated in:

ovarian dysfunctionDormant
BB
Indicative ·
64 / 100
View asset →
endocrine system disorderDormant
BB
Indicative ·
64 / 100
View asset →
polycystic ovary syndromeDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →